my research goal today was to explore whether this stock presents a buying opportunity for those building a diversified ...

However, Paul Hudson, CEO of Sanofi, one of the world's leading biopharmaceutical companies, says executives may need to rein ...

Sanofi, who will lead the global diabetes and cardiovascular care business unit in the company's new organisational structure. "The life sciences team at Google can help us improve the patient ...

Sanofi SAN0.01%increase; green up pointing triangle reported third-quarter earnings and sales that beat analysts’ expectations, boosted by earlier-than-anticipated deliveries of flu and ...

Through this agreement, Sanofi will transfer its technical expertise and global knowledge in biological technologies ... achieving pharmaceutical security, and effectively contributing to the ...

The global pharmaceutical major crushed the consensus analyst estimate for net income in its third quarter. It missed on sales, however. One reason investors were impressed by Sanofi's latest ...

Sanofi SAN-0.92%decrease; red down pointing triangle is in discussions with the French government to address concerns officials raised about a potential sale of a controlling stake in the company ...

"Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion," it said after French officials approved the deal ...

PARIS--(BUSINESS WIRE)--Regulatory News: Sanofi and Orano Med ... Orano Med has also developed a highly differentiating global industrial platform, which, thanks to its vast stock of raw materials ...

Weeks after penning a $110 million upfront deal with Orano Med for the global rights to a neuroendocrine tumor treatment, Sanofi has returned with 300 million euros ($326 million) to set up a more ...

Together, CD&R and Sanofi will support Opella’s growth strategy as a pure-play, global, and fast-moving consumer healthcare ... Also, please be aware that the security and privacy policies on these ...

"Sanofi and CD&R announce today a plan to join forces to fuel Opella’s ambitions as a French-headquartered, global consumer healthcare champion," it said after French officials approved the deal over ...